where are we at with hpv vaccine uptake? most provinces started in-school vaccination programs by 2010 for girls and by 2016 for boys. programs were disrupted during the covid-19 pandemic, so there’s a need for another educational push, salvador explains. while there was initial pushback about promoting promiscuity, the vaccine has nothing to do with sex. it’s a vaccine that prevents a vast majority of hpv-related cancers, including cervix, vulvar, vaginal and oral (the ears, nose and throat).
“vaccination rates are fluctuating between about 46 to 81 per cent, depending on the province, which means a national average around 65 per cent. that’s incredibly low. that’s not the herd immunity we need. we need our herd immunity to be upward over 80 into 90 per cent to really get adequate protection for everybody.”
health canada has approved the hpv vaccine for everyone up to age 45, but it is more effective for people under age 17 because their immune systems are robust, delivering a more aggressive immune response that’s going to be better and longer lasting. (as we get older, our immune systems aren’t quite as robust and functional.) the other reason is that vaccinating children before their first sexual debut is key because once you’ve been exposed to an hpv virus, the vaccine is not going to help fight off the hpv infection. it’s designed for prevention.
the first women to receive the hpv vaccine in canadian schools are now close to 30. “they’re just coming through where we would be screening them for developing pre-cancers and things like that. so that group is not old enough to be contributing to the cervix cancer rates that we’re seeing,” she says, pointing to the huge issue of accessing screening programs that have “fallen off the wayside.”
salvador raises access barriers, such as the lack of family doctors, so people are not being followed consistently and are left to stay informed about screenings on their own.